Blair Jackson

Senior Vice President of Corporate Planning, Alkermes

Blair Jackson leads Corporate Planning at Alkermes, encompassing Business Development, Business Planning, New Product Planning, Data Analytics, Procurement & Strategic Sourcing and Corporate Project Management. Previously, Mr. Jackson served on the board of Civitas Therapeutics, which was acquired by Acorda Therapeutics.  Mr. Jackson received a Bachelor of Arts degree in biochemistry from the University of Calgary, a Bachelor of Arts in Chemical Engineering, a Master of Business Administration from the University of Alberta, and a Master of Science in Chemical Engineering practice from the Massachusetts Institute of Technology.